Evidence map›Paper›PMID 37834390›Full record

ArticleInternational journal of molecular sciences2023

Drug-Tolerant

Elena G Ufimtseva, Natalya I Eremeeva

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. MakingCell insight · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Methods and Models for StudyingInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Elena G UfimtsevaLaboratory of Medical Biotechnology, Research Institute of Biochemistry, Federal Research Center of Fundamental and Translational Medicine, 2 Timakova Street, 630117 Novosibirsk, Russia.
Natalya I EremeevaInstitute of Disinfectology, F.F. Erisman Federal Scientific Center of Hygiene of the Federal Service on Surveillance for Consumer Rights Protection and Human Well-Being, 18a Nauchniy Proezd, 117246 Moscow, Russia.
Federal Research Center of Fundamental and Translational Medicine · RUUral research Institute of Phthisiopulmonology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid spread of drug-resistant

Indexed as

Mycobacterium tuberculosisTuberculosisTuberculosis, PulmonaryAntitubercular AgentsHumansMacrophages, AlveolarAntitubercular Agentsalveolar macrophagesbiomarkersdormancydrug toleranceMycobacterium tuberculosisnon-acid-fastnesspersistencepulmonary tuberculosisRv2623

Identifiers

PMID37834390
PMCPMC10573496
OpenAlexW4387401107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.